• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Cytosolic 5′-nucleotidase 1A (NT5C1A)

ACP02596

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP02596 Target NameNT5C1A
FormLiquid or Lyophilized powderExpression SystemYeast
Expression Range1-368aaMol Weight43.0kDa
Protein LengthFull lengthPurityGreater than 90% as determined by SDS-PAGE.
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9BXI3
Background Information
  • Uniprot Id

    Q9BXI3

  • Target Species

    Human

  • Target Name

    NT5C1A

  • Target Full Name

    Cytosolic 5'-nucleotidase 1A

  • Target Function

    Dephosphorylates the 5' and 2'(3')-phosphates of deoxyribonucleotides and has a broad substrate specificity. Helps to regulate adenosine levels in heart during ischemia and hypoxia.

  • Target Subcellular Location

    Cytoplasm.

  • Target Protein Families

    5'-nucleotidase type 3 family

  • Target Tissue Specificity

    Highly expressed in skeletal muscle. Detected at intermediate levels in heart, brain, kidney and pancreas.

  • Target Research Area

    Cardiovascular

  • Target Synonyms

    5' nucleotidase cytosolic IA; 5NT1A_HUMAN; AMP specific 5' NT; CN I; CN IA; cN-I; cN-IA; CN1; cN1A; cNI; cNIA; Cytosolic 5' nucleotidase 1A; Cytosolic 5' nucleotidase IA; Cytosolic 5' nucleotidase type 1A; Cytosolic 5''-nucleotidase 1A; Cytosolic 5''-nucleotidase IA; MGC119199; MGC119201; NT5C1A; nucleotidase; 5-prime; cytosolic; IA

Inquire Recombinant Human Cytosolic 5′-nucleotidase 1A (NT5C1A) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification